BPTH Company Profile and Key Details

Q: Who are the executives of BPTH?

Mr. Peter H. Nielsen MBACo-Founder, Chairman, Chief Executive Officer, Pres, Chief Financial Officer & TreasurerDr. Thomas A. Walker Ph.D.ConsultantDr. Alan MacKenzie Ph.D.ConsultantMr. Anthony PriceSenior Vice President of Fin., Accounting & Admin.Dr. Ana Tari Ashizawa Ph.D., MBASenior Vice President of Research, Devel. & Clinical DesignDr. Jeffery Lancet M.D.ConsultantMs. Victoria Lake RacRegulatory Consultant

NASDAQ : BPTH

Bio-Path

$0.03

0.0029+9.48%

At Close 4:00 PM

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Bio-Path Holdings, Inc. (BPTH) stock declined over -1.96%, trading at $0.03 on OTC, down from the previous close of $0.03. The stock opened at $0.04, fluctuating between $0.03 and $0.04 in the recent session.

Stock Snapshot

0.0306

Prev. Close

280.27K

Market Cap

0.03

Day Low

-0.04

P/E Ratio

-0.7189

EPS (TTM)

-18.67

Cash Flow per Share

0.04

Open

9.34M

Number of Shares

0.035

Day High

95.76%

Free Float in %

0.71

Book Value

50K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 18, 2026	0.04	0.04	0.03	0.03	59.06K
Aug 17, 2026	0.04	0.04	0.03	0.03	24.48K
Aug 14, 2026	0.04	0.04	0.04	0.04	5.35K
Aug 13, 2026	0.03	0.03	0.03	0.03	20.58K
Aug 12, 2026	0.04	0.04	0.04	0.04	91.83K
Aug 10, 2026	0.04	0.04	0.04	0.04	44.64K
Aug 07, 2026	0.04	0.04	0.04	0.04	48.23K
Aug 06, 2026	0.04	0.05	0.04	0.05	594
Aug 05, 2026	0.04	0.04	0.04	0.04	536
Aug 04, 2026	0.04	0.05	0.04	0.04	8.74K
Aug 03, 2026	0.04	0.04	0.04	0.04	724
Jul 31, 2026	0.04	0.04	0.04	0.04	4.5K
Jul 28, 2026	0.04	0.04	0.04	0.04	20.33K
Jul 27, 2026	0.04	0.04	0.04	0.04	1.13K
Jul 24, 2026	0.04	0.04	0.04	0.04	1.6K
Jul 23, 2026	0.04	0.04	0.04	0.04	5
Jul 22, 2026	0.04	0.05	0.04	0.04	28.2K
Jul 21, 2026	0.04	0.04	0.04	0.04	3.68K
Jul 20, 2026	0.04	0.04	0.04	0.04	1
Jul 17, 2026	0.05	0.05	0.04	0.04	16.28K

Contact Details

Bellaire, TX 77401

United States

https://www.biopathholdings.com 832 742 1357

About Company

Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refractory/relapsed lymphoma and chronic lymphocytic leukemia. Another promising asset, Liposomal STAT3, is in preclinical development, targeting pancreatic cancer, non-small cell lung cancer, and AML. Furthermore, prexigebersen-A is under development for various solid tumors. Bio-Path Holdings, Inc., founded in 2007, is headquartered in Bellaire, Texas.

Stock Peers

ODTC

Odonate Therapeutics, Inc.$2,849.50 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Frequently Asked Questions

What is the current Bio-Path Holdings, Inc. (BPTH) stock price?

Bio-Path Holdings, Inc. (OTC: BPTH) stock price is $0.03 in the last trading session. During the trading session, BPTH stock reached the peak price of $0.04 while $0.03 was the lowest point it dropped to. The percentage change in BPTH stock occurred in the recent session was -1.96% while the dollar amount for the price change in BPTH stock was - $0.00.

BPTH's industry and sector of operation?

The OTC listed BPTH is part of Biotechnology industry that operates in the broader Healthcare sector. Bio-Path Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BPTH?

Mr. Peter H. Nielsen MBA
Co-Founder, Chairman, Chief Executive Officer, Pres, Chief Financial Officer & Treasurer
Dr. Thomas A. Walker Ph.D.
Consultant
Dr. Alan MacKenzie Ph.D.
Consultant
Mr. Anthony Price
Senior Vice President of Fin., Accounting & Admin.
Dr. Ana Tari Ashizawa Ph.D., MBA
Senior Vice President of Research, Devel. & Clinical Design
Dr. Jeffery Lancet M.D.
Consultant
Ms. Victoria Lake Rac
Regulatory Consultant

How BPTH did perform over past 52-week?

BPTH's closing price is 235% higher than its 52-week low of $0.01 where as its distance from 52-week high of $0.13 is -76.07%.

How many employees does BPTH have?

Number of BPTH employees currently stands at 1.

Link for BPTH official website?

Official Website of BPTH is: https://www.biopathholdings.com

How do I contact BPTH?

BPTH could be contacted at phone 832 742 1357 and can also be accessed through its website. BPTH operates from 4710 Bellaire Boulevard, Bellaire, TX 77401, United States.

How many shares of BPTH are traded daily?

BPTH stock volume for the day was 50K shares. The average number of BPTH shares traded daily for last 3 months was 23.56K.

What is the market cap of BPTH currently?

The market value of BPTH currently stands at $280.27K with its latest stock price at $0.03 and 9.34M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1
Beta	-0.5
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	1
Beta	-0.5
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

BPTH Company Profile and Key Details

Bio-Path

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Valuation Metrics

Key Takeaways

Price Forecast & Outlook